Dermot McGovern

Dr. McGovern is a gastroenterologist and preeminent geneticist in the IBD field. Dr. McGovern completed his GI fellowship and obtained a Ph.D. in complex disease genetics at the University of Oxford, England before moving to Cedars-Sinai. Dr. McGovern is the Director of Translational Medicine at Cedars, co-Director of the Cedars-Sinai IBD repository (MIRIAD) and IBD Database, and was recently appointed the Director of Precision Health at Cedars-Sinai. Dr. McGovern serves on both the Steering Committee of the NIDDK IBD Genetics Consortium and on the Management Committee of the International IBD Genetics Consortium. Dr. McGovern is one of the founding members of Precision IBD, the predecessor of Prometheus Biosciences, and serves as the consulting geneticist and provides input on the patient selection criteria.